liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Limbal Stem Cells and Corneal Homeostasis: Insights from Models, Transcriptomics, and Drug Repurposing
Linköping University, Department of Biomedical and Clinical Sciences, Division of Sensory Organs and Communication. Linköping University, Faculty of Medicine and Health Sciences.
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Limbal stem cell deficiency (LSCD) is an important cause of visual impairment and, in severe cases, can lead to blindness. It is clinically diagnosed based on corneal surface manifestations, including conjunctivalization, vascular invasion and epithelial instability. These signs are often interpreted as indicating loss of the stem cells located at the outer border of the cornea, known as the limbus, which may lead to the decision to perform a stem cell transplantation. Yet clinical features of LSCD can occur without destruction of the limbal niche, and the fate of LSCs in a completely or partially preserved niche is poorly characterized. This gap is particularly relevant to aniridia-associated keratopathy (AAK), a rare congenital disease with poorly understood mechanisms. Importantly, even the healthy limbus lacks a well-characterized gene expression signature at the resolution needed to capture its complexity due to the limitations of individual technologies. This thesis addressed these gaps and examined how LSCs respond to loss of corneal homeostasis when the niche is not totally destroyed, and whether an altered limbal state can be modulated pharmacologically. To this aim, two mouse models were employed. First, congenital Pax6 haploinsufficiency, mimicking human AAK, revealed several mechanisms of impaired postnatal corneal maturation, dysregulated pathways and potential therapeutic targets. Second, a suture-induced inflammatory neovascularization model was used through which transformation of LSCs after injury and LSCD-mimicking conjunctivalization were studied in detail. Employing drug repurposing as a treatment strategy not only identified duloxetine as a potential therapy for corneal inflammation but showed it can modulate LSC transformation after injury. In addition, to better define the LSC state in a healthy cornea, a methodology was developed to provide a detailed molecular reference for mouse LSCs that, to our knowledge, has not previously been established at such high resolution within their niche in a tissue context. This approach revealed four LSC subpopulations defined by broad gene profiles confined to the limbal region in the mouse cornea. Nichesparing LSCD is therefore better described as a pharmacologically accessible shift in LSC transcriptional state than as loss of stem cells, making state modulation a potential alternative to cell replacement.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2026. , p. 45
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 2055
Keywords [en]
Limbal stem cells, limbal stem cell deficiency, corneal homeostasis, aniridia-associated keratopathy, PAX6, corneal neovascularization, conjunctivalization, single-cell RNA sequencing, spatial transcriptomics, drug repurposing
National Category
Ophthalmology Cell and Molecular Biology Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:liu:diva-228261DOI: 10.3384/9789181186345ISBN: 9789181186338 (print)ISBN: 9789181186345 (electronic)OAI: oai:DiVA.org:liu-228261DiVA, id: diva2:2107764
Public defence
2026-10-30, Belladonna, Salix and Kanel, Campus US, Linköping, 09:00 (English)
Opponent
Supervisors
Available from: 2026-10-05 Created: 2026-10-05 Last updated: 2026-10-14Bibliographically approved
List of papers
1. A human-like model of aniridia-associated keratopathy for mechanistic and therapeutic studies
Open this publication in new window or tab >>A human-like model of aniridia-associated keratopathy for mechanistic and therapeutic studies
Show others...
2025 (English)In: JCI Insight, ISSN 2379-3708, Vol. 10, no 2, article id e183965Article in journal (Refereed) Published
Abstract [en]

Aniridia is a rare congenital condition of abnormal eye development arising principally from heterozygous mutation of the PAX6 gene. Among the multiple complications arising in the eye, aniridia-associated keratopathy (AAI() is a severe vision-impairing condition of the cornea associated with a progressive limbal stem cell deficiency that lacks suitable treatment options. Current mouse models of aniridia do not accurately represent the onset and progression dynamics of human AAI(, hindering therapy development. Here, we performed deep phenotyping of a haploinsufficient Pax6 +/- small-eye (Sey) mouse model on the 129S1/SvImJ background, which exhibits key features of mild presentation at birth and progressive AAI( with aging, mimicking human disease. The model exhibits a slowly progressing AAI( phenotype and provides insights into the disease, including disturbed basal epithelial cell organization, function, and marker expression; persistent postnatal lymphangiogenesis; disrupted corneal innervation patterns; and persisting yet altered limbal stem cell marker expression with age. The model recapitulates many of the known features of human disease, enabling investigation of underlying disease mechanisms and, importantly, access to a well-defined temporal window for evaluating future therapeutics.

Place, publisher, year, edition, pages
AMER SOC CLINICAL INVESTIGATION INC, 2025
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:liu:diva-211599 (URN)10.1172/jci.insight.183965 (DOI)001406947800001 ()39625791 (PubMedID)2-s2.0-85216426799 (Scopus ID)
Note

Funding Agencies|European Union through the European Joint Programme [EJPRD20-135]

Available from: 2025-02-11 Created: 2025-02-11 Last updated: 2026-10-05
2. Transcriptomic Analysis in a Model of Aniridia-Associated Keratopathy for Target Discovery and Evaluation of Duloxetine Therapy
Open this publication in new window or tab >>Transcriptomic Analysis in a Model of Aniridia-Associated Keratopathy for Target Discovery and Evaluation of Duloxetine Therapy
Show others...
2026 (English)In: Investigative Ophthalmology and Visual Science, ISSN 0146-0404, E-ISSN 1552-5783, Vol. 67, no 1, article id 37Article in journal (Refereed) Published
Abstract [en]

PURPOSE. Aniridia-associated keratopathy (AAK) leads to loss of corneal transparency because of epithelial, inflammatory, and pathological vascular changes. Here, we sought to understand this process at the transcriptomic level while evaluating an experimental pharmacotherapy for potential modulatory effects. METHOD. 17 Pax6+/- Small-eye (Sey) heterozygous mice with p.Gly208* Pax6 mutation and 10 wild-type 129S1/SvImJ mice at four months of age were examined to identify dysregulated genes and pathways in established AAK. We next evaluated the potential efficacy of 10 mu M duloxetine administered as eye drops twice daily for 90 days, assessing outcomes at the transcriptomic level via microarray and protein level with Western blot and immunostaining. RESULTS. Transcriptomic analysis of the cornea revealed enrichment of Ccl21 gene family members associated with lymphangiogenesis, along with upregulation of genes involved in inflammation, cell adhesion, differentiation, motility, and keratinization, and downregulation of drug metabolism with significantly dysregulated genes emerging as potential therapeutic targets, including Gpha2, Chrnb3, Epgn, Cnfn, kallikreins and inflammation mediators Il18r1 and classical complement factors. Duloxetine therapy failed to regress AAK in adult corneas; however, transcriptomic profiling indicated duloxetine suppressed inflammatory genes and promoted anti-inflammatory and protective activity while modulating drug metabolism, suggesting potential beneficial effects in the cornea. CONCLUSIONS. Transcriptomics reveals multiple unexplored pathways and genes altered in the AAK mouse model. Although clinical results with duloxetine are promising, our current regimen and delivery method did not improve established disease. Duloxetine's therapeutic potential requires further study.

Place, publisher, year, edition, pages
ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2026
Keywords
cornea; aniridia associated keratopathy; transcriptomics; PAX6; ocular surface; duloxetine; inflammation; lymphangiogenesis
National Category
Neurosciences
Identifiers
urn:nbn:se:liu:diva-220957 (URN)10.1167/iovs.67.1.37 (DOI)001669295300001 ()41543334 (PubMedID)2-s2.0-105027705226 (Scopus ID)
Note

Funding Agencies|European Union through the EU Horizon Europe RESTORE VISION project [101080611]; European Joint Programme on Rare Diseases (EJP-RD) under the project AAK-INSIGHT [EJPRD20-135]

Available from: 2026-02-03 Created: 2026-02-03 Last updated: 2026-10-05
3. Perturbation of epithelial and limbal stem cell identity in a mouse model of pathologic corneal neovascularization
Open this publication in new window or tab >>Perturbation of epithelial and limbal stem cell identity in a mouse model of pathologic corneal neovascularization
Show others...
2026 (English)In: Communications Biology, E-ISSN 2399-3642Article in journal (Refereed) In press
Abstract [en]

The epithelial layer of the cornea is a critical physical and ocular immune barrier. Corneal injury can trigger inflammation and an aggressive wound healing response that can compromise immune privilege and avascularity, leading to vision loss. The effects of chronic inflammation on limbal stem cell (LSC) function and its ability to renew the epithelium, however, remain unclear. Here, we use a corneal suture model in C57Bl/6 male mice to induce epithelial damage, inflammation and neovascularization, to examine the impact on LSCs. Using single-cell transcriptomics, we evaluate corneal cell state changes and the potential of duloxetine, an FDA-approved medicine, to promote corneal homeostasis. We show with single-cell RNA-seq analysis a loss of homeostatic LSCs, basal, and differentiated epithelial cells, and an increase in transformed LSC, conjunctival, inflammatory, and vascular cell states following cornea injury, suggesting a coordinated wound healing response in different tissue layers. We show duloxetine promotes epithelial homeostasis, LSC identity maintenance, epithelial and stromal repair, and suppression of immune and vascular responses. The current treatment regimen is, however, insufficient to improve the corneal phenotype in the short term. Single-cell level dynamics reveal detailed drug modes of action, highlighting key aspects of LSC and corneal cell plasticity during tissue repair.

Place, publisher, year, edition, pages
Springer Nature, 2026
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:liu:diva-228556 (URN)10.1038/s42003-026-10737-4 (DOI)
Note

Funding: Funding for this study was obtained (to N.L. and H.Z.) from the European Joint Programme on Rare Diseases (EJP-RD) under the project AAK-INSIGHT, Grant No. EJPRD20-135. Funding was also obtained (to N.L.) from the European Union Horizon Europe Programme under the project RESTORE VISION, Grant No. 101080611. The funders had no role in the design, conduct or reporting of the results in this study. Open access funding provided by Linköping University.

Available from: 2026-10-14 Created: 2026-10-14 Last updated: 2026-10-14

Open Access in DiVA

fulltext(4146 kB)116 downloads
File information
File name FULLTEXT01.pdfFile size 4146 kBChecksum SHA-512
e75f9cd5f7a0f0480b7aa3a677b120edc89f098c8e65af6aa9ba8b411f9d23b5368776c7cc09eb491be891b389ed3b0ee808287cf6b0e8ebe12de76e97da1ea1
Type fulltextMimetype application/pdf
Order online >>

Other links

Publisher's full text

Authority records

Javidjam, Dina

Search in DiVA

By author/editor
Javidjam, Dina
By organisation
Division of Sensory Organs and CommunicationFaculty of Medicine and Health Sciences
OphthalmologyCell and Molecular BiologyPharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 116 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
isbn
urn-nbn

Altmetric score

doi
isbn
urn-nbn
Total: 2773 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf